Professor and Head of Cardiology Teaching and Research at the University of Notre Dame, Fremantle, Australia. Consultant Clinical Cardiologist specializing in Cardiac Imaging and breathlessness assessment. Regular invited speaker to National and International conferences and many highly cited publications Founder, Director and Chief Investigator of National Echo Database Australia (NEDA). Advisor to Echo IQ, an ASX listed company focused on automation and risk detection using echocardiographic data (ASX:EIQ).

Johan Verjans is a cardiometabolic and imaging cardiologist who founded and leads the Medical Machine Learning group at the Australian Institute for Machine Learning. His research focuses on developing and implementing AI methods in biomedical and clinical contexts, driving innovation, translational impact, and real-world integration of medical AI solutions.

Professor Girish Dwivedi, MD, DM, MRCP (UK), PhD (UK), FESC, FASE, FSCCT, FCSANZ, is the inaugural Wesfarmers Chair in Cardiology at the Harry Perkins Institute of Medical Research, University of Western Australia (UWA), and Consultant Cardiologist at Fiona Stanley Hospital, Murdoch, Perth. He leads the "Advanced Clinical and Translational Cardiovascular Imaging" group at the Harry Perkins Institute of Medical Research (University of Western Australia) and also holds the position of Joint Head of the Cardiovascular Disease and Diabetes Program at Perkins, as well as serving as the Director of the Cardiometabolic Clinic at the Centre for Cardiometabolic Health and Research, Fiona Stanley Hospital. He has >250 manuscripts accepted or published. Several of his original research manuscripts have been published in top-tier journals such as Annals of Internal Medicine, JACC, Circulation, JACC-Imaging, and Circulation Heart Failure. He has written chapters in a highly prestigious book in Cardiology (Principles and Practice of Clinical Cardiovascular Genetics published by Oxford University Press). His group has conducted pioneering work examining the association of inflammation and atherosclerosis. He has utilized a trans-disciplinary approach that involves translational medicine and novel cardiovascular imaging methods in assessing subclinical atherosclerosis in distinct inflammatory clinical phenotypes. This body of work has received many grants and generated several publications in high-impact journals such as Annals of Internal Medicine, Chest, Journal of Nuclear Cardiology, and AJP-Heart and Circulatory Physiology. After arriving in Perth, he has collaborated closely with the Computer Science colleagues at UWA. Dr. Dwivedi started working with a MedTech start-up company based in Perth (Artrya Ltd) soon after its inception as the Chief Medical Officer and as Chief Scientific Officer (since 2021). Their joint research program is focused on the development of artificial intelligence algorithms to automate advanced and novel cardiac CT biomarker assessment towards heart disease events. Dr. Dwivedi contributed to the development of the intellectual property, resulting in a TGA approved product.

Henry is a Basic Physician Trainee at Royal Prince Alfred, Sydney, and a Clinical Lecturer at the University of Sydney. He is a scientist trained at the University of Oxford where he completed his doctorate as a Rhodes Scholar, and a post-doctoral period working on AI approaches to CT interpretation. He is currently focused on novel imaging biomarkers for atrial fibrillation and ischaemic stroke through the ORFAN Study, the world’s largest CT coronary angiogram cohort study.

Jessica is a Principal Research Fellow at the School of Public Health, University of Sydney. Jessica is the Editor-in-Chief, Journal of Science and Medicine in Sport Plus and director of the Australasian Registry of ECGs in National Athletes (ARENA). Jessica’s research aims to improve the quality of cardiac screening programs to prevent sudden cardiac death and stroke.

Johan Verjans is a cardiometabolic and imaging cardiologist who founded and leads the Medical Machine Learning group at the Australian Institute for Machine Learning. His research focuses on developing and implementing AI methods in biomedical and clinical contexts, driving innovation, translational impact, and real-world integration of medical AI solutions.

Dr Andrew Lin is a Consultant Cardiologist, Academic Lead of Cardiac Imaging, and Director of the Atherosclerosis Imaging Core Laboratory at the Victorian Heart Hospital. He runs a research program focused on the discovery and application of novel imaging biomarkers to improve diagnostic and prognostic precision. He is a NHMRC Emerging Leadership Fellow and previous Heart Foundation Postdoctoral Fellow. His PhD applied advanced quantitative techniques and AI to phenotype plaque and pericoronary adipose tissue on coronary CT angiography. He then undertook a postdoctoral fellowship in AI-enabled coronary plaque analysis at the Cedars-Sinai Medical Center Biomedical Imaging Research Institute. He has received multiple international young investigator awards for his research, including from the American College of Cardiology and Society of Cardiovascular Computed Tomography.

A/Prof Paratz is a clinician-researcher, with a research programme focussed on sudden cardiac arrest and big data, and subspecialty expertise in cardiac imaging. She works primarily at St Vincent's Institute of Medical Research and St Vincent's Hospital Melbourne.